Cytosorbents Corp — Director's Dealing 2011

Sep 9, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2011-09-06

Reporting Person: Lamadrid David (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-09-06	Common Stock	S	12500	$0.215	Disposed	7837500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-09-06	Stock Option	$0.035	M	12500	Disposed		Common Stock (12500)	Direct

Footnotes

F1: The shares of common stock were sold by Mr. Lamadrid pursuant to a 10b5-1 trading plan, adopted by the reporting person on June 8, 2011.

F2: In addition to the currently outstanding shares of common stock owned by Mr. Lamadrid and reported here, Mr. Lamadrid also beneficially owns the shares of common stock underlying the following stock options: options to purchase 150,000 shares of common stock at $1.90 per share; options to purchase 1,400,000 shares of common stock at $0.25 per share; options to purchase 400,000 shares of common stock at $0.173 per share; options to purchase 400,000 shares of common stock at $0.168 per share, options to purchase 2,750,000 shares of common stock at $0.138 per share; and options to purchase 2,737,500 shares of common stock at $0.035 per share.

F3: N/A